Optima has delivered a filling system to Catalent‘s biologics facility in Bloomington, IN, US. The vial system with an isolator is the second vial line to be installed at the site and will be used initially for the filling of a vaccine candidate to fight covid-19 (SARS-CoV-2).

The first partial shipment to the US was at the beginning of August. An Antonov An-124 cargo aircraft was chartered for transportation.

Catalent is investing US$50 million (£38 million) to install a  third high-speed vial filling line, which is expected to be operational by April 2021 and has capacity to produce up to 80 million vials annually under barrier isolator technology and a peristaltic pump filling mechanism, consistent with cGMP. The company said that by the end of 2021 the site would have high-speed filling capacity across three vial lines, two syringe lines, and a flexible line capable of filling vials, syringes, or cartridges. The facility has expertise in sterile formulation, with drug substance development and manufacturing and drug product fill-finish capacity, including primary and secondary packaging.

Link to Optima Press Release

Link to Catalent Press Release

Comment on this article

See what ondrugdelivery's readers and contributors think

Matt Kempton user photo
Matt Kempton
Snr Project Engineer
Corning Incorporated

I am extremely impressed with the comprehensive presentation of information and problem/solution points detailed ... Kudos to you for an extremely well written article with succinct and robust scientific body of knowledge.

Dr Cristian Vilos

I‘m working on the development of microparticles for the release of veterinary antibiotics, and polymeric nanoparticles for siRNA and chemotherapeutic delivery. ONdrugDelivery has been a very usefull platform to connect the scientific research, and marketed drug development.

Donna Bibber
Micro Engineering Solutions

I picked up your latest copy at the Boston PODD event and read it with great interest. You’ve really come a long way and you put out an amazingly professional and value-packed magazine.

Li-Chun Tsou, PhD, MBA
Principal Engineer
Merck & Co

Your website and publication is a great asset for me. I’d recommend your publication to my colleagues. I am sure that we will gain knowledge and update information through your timely report. Thanks for making it available.